As an IT Executive I recently began to utilize Twitter as a more professional tool to communicate with my associates and industry peers - - I certainly am not going to Facebook friend people who work for me nor people in the industry that I would like to maintain a bit more of a professional relationship with. And LinkedIn is just too awkward of a user interface to be a quick sharing tool. So I am highly impressed with Twitter and do believe that it is a different and I will use the word unique social media platform. So impressed so that I am looking to take an initial LONG position in TWTR.
If GILD ATTEMPTS to buy INCY that will not be the last word. I believe this would begin a bidding war. And in that scenario - the sky is the limit.
Actually buying the corporate HQ might actually be tip off that a foreign based Pharma could be the acquirer.
With many of the traders away in the Hamptons for August this whole Chinese scare has one purpose: drop equity prices to unrealistic lows forcing the mom and pop investors to panic sell their shares and the big boys buy 'em up! Then everyone comes back in September and the market rockets higher only those benefiting are not the mom and pops but the professionals who now own their shares! This is standard rotation not in sectors but in owners! Makes me sick to see mom and pop falling to this oldest trick in the book!
HOLD ONTO YOUR SHARES!
Adding to that: Bicster is quite a bigot stating he believes FSAID, a condition that affects countless women is imaginary! Are you crazy?!
We all keep hearing Sprout's pink pill being referred to as the female Viagra. To know your science, Sprout's pink pill actually affects a women's Brain not her blood flow; AND brings with it many concerning side affects.
Today's sale of Sprout's pink pill for $1 Billion I think values Femprox at least as much because Femprox affects blood flow of the female reproductive system and therefore in my mind is more correctly the female Viagra.
We are positioned quite nicely here as someone has paid $1 Billion for a house on this block. And our house is bigger, better landscaped, and freshly painted!
LONG AND STRONG!
Absolutely Social - - this is an asset on the shelves for any marketer to grab and make money from; and WE make money too. Prior to today Femprox had zero value measured in the stock price. Today we should see an appreciable lift in share price as this value is recognized. Not saying that value is $1 Billion but it has some kind of value don't you think???
And BIC Pascoe is SO SMART to float the Femprox partner press release the day before Sprout is sold! Like it or not THAT is how a smart CEO skippers the ship!
On August 10, 2015, the Company announced that Vitaros�, its topical cream indicated for the treatment of patients with erectile dysfunction, has been approved through the European Decentralized Procedure ("DCP") in twelve additional countries. Those countries are: Austria, Cyprus, the Czech Republic, Denmark, Finland, Greece, Iceland, Norway, Poland, Portugal, Romania and the Slovak Republic. The Company's commercialization partners that hold the licenses for these additional territories are responsible for the next step of obtaining national phase approvals in order to move Vitaros� closer to launch in those territories.
Someone is really shaking the bushes today on APRI - - I think the corporate update may include some tidbits that would encourage a long position here. Don't let go of your shares and use this volatile action in the PPS to your advantage to get more shares!
ROVI is HOPELESS! What a significant disappointment indeed!
Things appear to be going from Bad to Worse. With all of this negative PR even a buyout of the company would be for far less of a premium. I smell a Fire Sale!
News is that the carriage doors have opened and our Belle has arrived at the ball.
Who knows where this ends - - a wise man once told me everything in life depends on how much the buyer wants to buy and the seller wants to sell....